Biggest News Aggregation in the World
📰 Resources Report News

Page 2 - Resources Report News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Resources Report. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Exelixis Announces Detailed Results from Phase 3 COSMIC-313 Pivotal Trial in Patients with Previousl

– Cabozantinib in combination with nivolumab and ipilimumab significantly reduced the risk of disease progression or death compared with the combination of nivolumab and ipilimumab –– Median progression-free survival was not yet reached with the combination of cabozantinib, nivolumab and ipilimumab versus 11.3 month...
United States Toni Choueiri Susan Hubbard Vickil Goodman Lindsay Treadway Nancy Kohlberg

Exelixis Announces Detailed Results from Phase 3 COSMIC-313 Pivotal Trial in Patients with Previously Untreated Advanced Kidney Cancer at ESMO 2022

08.09.2022 - Exelixis, Inc. (Nasdaq: EXEL) today announced detailed results from COSMIC-313, an ongoing phase 3 pivotal trial evaluating the combination of cabozantinib (CABOMETYX), nivolumab and ipilimumab versus the combination of nivolumab and ipilimumab in ...
United States Vickil Goodman International Metastatic Daiichi Sankyo Company Genentech Inc Takeda Pharmaceutical Company

Exelixis, Inc.: Exelixis Announces Detailed Results from Phase 3 COSMIC-313 Pivotal Trial in Patients with Previously Untreated Advanced Kidney Cancer at ESMO 2022

- Cabozantinib in combination with nivolumab and ipilimumab significantly reduced the risk of disease progression or death compared with the combination of nivolumab and ipilimumab - - Median progression-free
United States Toni Choueiri Susan Hubbard Vickil Goodman Lindsay Treadway Nancy Kohlberg

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science